| Market Cap | 4.17B | P/E | 17.62 | EPS this Y | -15.00% | Ern Qtrly Grth | -10.10% |
| Income | 211.01M | Forward P/E | 25.90 | EPS next Y | 2.60% | 50D Avg Chg | 14.00% |
| Sales | 1.13B | PEG | 6.79 | EPS past 5Y | 16.27% | 200D Avg Chg | - |
| Dividend | 6.00% | Price/Book | 0.76 | EPS next 5Y | 3.20% | 52W High Chg | -35.00% |
| Recommedations | 2.60 | Quick Ratio | 2.14 | Shares Outstanding | 117.37M | 52W Low Chg | 36.00% |
| Insider Own | 2.22% | ROA | 1.86% | Shares Float | 114.56M | Beta | 1.03 |
| Inst Own | 112.60% | ROE | 4.21% | Shares Shorted/Prior | 7.76M/7.30M | Price | 35.23 |
| Gross Margin | 68.92% | Profit Margin | 18.79% | Avg. Volume | 1,196,738 | Target Price | 41.15 |
| Oper. Margin | 27.76% | Earnings Date | May 2 | Volume | 1,295,803 | Change | 0.26% |
Kilroy Realty Corporation (NYSE: KRC, the company, Kilroy) is a leading U.S. landlord and developer, with operations in San Diego, Greater Los Angeles, the San Francisco Bay Area, Greater Seattle and Austin. The company has earned global recognition for sustainability, building operations, innovation and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science and business services companies. The company is a publicly traded real estate investment trust (REIT) and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring and managing office, life science and mixed-use projects. As of December 31, 2023, Kilroy's stabilized portfolio totaled approximately 17.0 million square feet of primarily office and life science space that was 85.0% occupied and 86.4% leased. The company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 92.5%. In addition, the company had two in-process life science redevelopment projects totaling approximately 100,000 square feet with total estimated redevelopment costs of $80.0 million and one approximately 875,000 square foot in-process development project with a total estimated investment of $1.0 billion.
| Barclays | Equal-Weight | Mar 27, 24 |
| RBC Capital | Sector Perform | Mar 8, 24 |
| Keybanc | Overweight | Feb 28, 24 |
| Deutsche Bank | Hold | Jan 30, 24 |
| Wolfe Research | Peer Perform | Dec 15, 23 |
| Mizuho | Buy | Oct 18, 23 |
| Jefferies | Buy | Oct 13, 23 |
| Goldman Sachs | Buy | Oct 12, 23 |
| Keybanc | Overweight | Sep 12, 23 |